TuisFOLD • NASDAQ
add
Amicus Therapeutics, Inc.
Vorige sluiting
$7,20
Dagwisseling
$7,05 - $7,38
Jaarwisseling
$6,20 - $12,65
Markkapitalisasie
2,26 mjd USD
Gemiddelde volume
3,54 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 149,71 m | 30,09% |
Bedryfskoste | 118,90 m | 10,66% |
Netto inkomste | 14,74 m | 143,55% |
Netto winsgrens | 9,85 | 133,49% |
Wins per aandeel | 0,09 | 800,00% |
EBITDA | 18,01 m | 1 292,85% |
Effektiewe belastingkoers | -85,77% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 249,95 m | -12,67% |
Totale bates | 785,03 m | 0,92% |
Totale aanspreeklikheid | 590,99 m | -4,33% |
Totale ekwiteit | 194,04 m | — |
Uitstaande aandele | 300,12 m | — |
Prys om te bespreek | 11,08 | — |
Opbrengs op bates | 5,08% | — |
Opbrengs op kapitaal | 6,33% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 14,74 m | 143,55% |
Kontant van bedrywe | -3,92 m | -213,24% |
Kontant van beleggings | -20,39 m | 14,88% |
Kontant van finansiering | 1,10 m | -86,64% |
Netto kontantverandering | -20,10 m | -24,14% |
Beskikbare kontantvloei | 8,65 m | 215,80% |
Meer oor
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
Gestig
04 Feb. 2002
Webwerf
Werknemers
499
